GlassScriptPhysician profile
William Geoffrey Scott
NPI 1689601072
$1,763.73
in general payments reported to CMS, 2019-2025
17 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.52 · 2020: $14.43 · 2021: $35.18 · 2022: $1,156 · 2023: $82.57 · 2024: $205 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,008.06 | 2022 | |
| Alk-Abello, INC | $115.68 | 2022-2025 | Pre-Pen, Alternaria Tenuis, Standardized Mite D. Farinae |
| Optinose US, INC. | $109.44 | 2024-2025 | |
| Acclarent, INC | $95.14 | 2021-2022 | |
| Medtronic, INC. | $86.52 | 2022-2025 | Propel, Pteye Parathyroid Detection System |
| Regeneron Healthcare Solutions, INC. | $83.12 | 2022-2023 | Dupixent |
| Glaxosmithkline, LLC. | $53.72 | 2025 | Nucala |
| Inspire Medical Systems, INC. | $49.19 | 2023 | Inspire |
| Stryker Corporation | $28.67 | 2019 | |
| Genzyme Corporation | $25.79 | 2025 | |
| Smith+Nephew, INC. | $20.59 | 2025 | Halo, Tula |
| Philips North America LLC | $19.94 | 2019 | |
| Phathom Pharmaceuticals, INC. | $15.94 | 2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $14.91 | 2019 | |
| Cochlear Americas | $14.43 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $13.59 | 2024 | Ryaltris |
| Glenmark Therapeutics INC. | $9.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.